Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Cyclical Evolution of the Global Right.
Chase-Dunn C, Grimes P, Anderson EN.
Can Rev Sociol. 2019 Nov;56(4):529-555. doi: 10.1111/cars.12263.
Similar articles
Racial and Ethnic Differences in Self-Assessed Facial Aging in Women: Results From a Multinational Study.
Alexis AF, Grimes P, Boyd C, Downie J, Drinkwater A, Garcia JK, Gallagher CJ.
Dermatol Surg. 2019 Dec;45(12):1635-1648. doi: 10.1097/DSS.0000000000002237.
Safety and Effectiveness of VYC-17.5L for Long-Term Correction of Nasolabial Folds.
Dayan S, Maas CS, Grimes PE, Beer K, Monheit G, Snow S, Murphy DK, Lin V.
Aesthet Surg J. 2019 Jul 26. pii: sjz200. doi: 10.1093/asj/sjz200. [Epub ahead of print]
In Vitro and In Vivo Efficacy and Tolerability of a Non-Hydroquinone, Multi-Action Skin Tone Correcting Cream
Grimes PE, McDaniel DH, Wortzman M, Nelson D.
J Drugs Dermatol. 2019 Jul 1;18(7):642-648.
Myths and Knowledge Gaps in the Aesthetic Treatment of Patients With Skin of Color
Alexis AF, Few J, Callender VD, Grimes P, Downie J, Boyd C, Gallagher CJ.
J Drugs Dermatol. 2019 Jul 1;18(7):616-622.
Polymethylmethacrylate Collagen Gel-Injectable Dermal Filler for Full Face Atrophic Acne Scar Correction.
Joseph JH, Shamban A, Eaton L, Lehman A, Cohen S, Spencer J, Bruce S, Grimes P, Tedaldi R, Callender V, Werschler P.
Dermatol Surg. 2019 Dec;45(12):1558-1566. doi: 10.1097/DSS.0000000000001863.
New oral and topical approaches for the treatment of melasma.
Grimes PE, Ijaz S, Nashawati R, Kwak D.
Int J Womens Dermatol. 2018 Nov 20;5(1):30-36. doi: 10.1016/j.ijwd.2018.09.004. eCollection 2019 Feb.
Comparison of 311-nm Titanium:Sapphire laser and 308-nm excimer laser treatment for vitiligo: A randomized controlled non-inferiority trial.
Bae JM, Eun SH, Lee HN, Kim GM, Grimes PE, Lee JH.
Lasers Surg Med. 2019 Mar;51(3):239-244. doi: 10.1002/lsm.23048. Epub 2019 Jan 25.
A closer look at the role of the dermatologist in championing total women's health through the dermatology gateway.
Grimes PE.
Int J Womens Dermatol. 2018 Nov 15;4(4):189-192. doi: 10.1016/j.ijwd.2018.09.006. eCollection 2018 Dec.
International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation.
Eleftheriadou V, Hamzavi I, Pandya AG, Grimes P, Harris JE, Huggins RH, Lim HW, Elbuluk N, Bhatia B, Tovar-Garza A, Nahhas AF, Braunberger T, Ezzedine K.
Br J Dermatol. 2019 Mar;180(3):574-579. doi: 10.1111/bjd.17013. Epub 2018 Oct 5.
Vitiligo: Patient stories, self-esteem, and the psychological burden of disease.
Grimes PE, Miller MM.
Int J Womens Dermatol. 2018 Jan 8;4(1):32-37. doi: 10.1016/j.ijwd.2017.11.005. eCollection 2018 Mar.
Safety and Effectiveness of the Hyaluronic Acid Dermal Filler VYC-17.5L for Nasolabial Folds: Results of a Randomized, Controlled Study.
Monheit G, Beer K, Hardas B, Grimes PE, Weichman BM, Lin V, Murphy DK.
Dermatol Surg. 2018 May;44(5):670-678. doi: 10.1097/DSS.0000000000001529.
Considerations When Treating Cosmetic Concerns in Men of Color.
Awosika O, Burgess CM, Grimes PE.
Dermatol Surg. 2017 Nov;43 Suppl 2:S140-S150. doi: 10.1097/DSS.0000000000001376. Review.
The Role of Diet and Supplements in Vitiligo Management.
Grimes PE, Nashawati R.
Dermatol Clin. 2017 Apr;35(2):235-243. doi: 10.1016/j.det.2016.11.012. Review.
Depigmentation Therapies for Vitiligo.
Dermatol Clin. 2017 Apr;35(2):219-227. doi: 10.1016/j.det.2016.11.010. Review.
Bimatoprost 0.03% Solution for the Treatment of Nonfacial Vitiligo.
J Drugs Dermatol. 2016 Jun 1;15(6):703-10.
Updates in the understanding and treatments of skin and hair disorders in women of color.
Int J Womens Dermatol. 2015 May 29;1(2):76. doi: 10.1016/j.ijwd.2015.05.001. eCollection 2015 Jun. No abstract available.
Living with vitiligo: results from a national survey indicate differences between skin phototypes.
Ezzedine K, Grimes PE, Meurant JM, Seneschal J, Léauté-Labrèze C, Ballanger F, Jouary T, Taïeb C, Taïeb A.
Br J Dermatol. 2015 Aug;173(2):607-9. doi: 10.1111/bjd.13839. Epub 2015 Jul 28. No abstract available.
Indications and limitations of afamelanotide for treating vitiligo-reply.
Lim HW, Grimes PE, Lebwohl M.
JAMA Dermatol. 2015 Mar;151(3):350. doi: 10.1001/jamadermatol.2014.4951. No abstract available.
Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, Linkner RV, Lebwohl M.
JAMA Dermatol. 2015 Jan;151(1):42-50. doi: 10.1001/jamadermatol.2014.1875.
Histopathological progression of a mycosis fungoides mimic to classic vitiligo.
Kaskas NM, DiGiorgio C, Nicotri T, Hooper D, Grimes P.
J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1856-7. doi: 10.1111/jdv.12546. Epub 2014 May 12. No abstract available.
A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne scars.
Karnik J, Baumann L, Bruce S, Callender V, Cohen S, Grimes P, Joseph J, Shamban A, Spencer J, Tedaldi R, Werschler WP, Smith SR.
J Am Acad Dermatol. 2014 Jul;71(1):77-83. doi: 10.1016/j.jaad.2014.02.034. Epub 2014 Apr 13.
Novel skin brightener used as monotherapy for moderate melasma in skin of color.
J Drugs Dermatol. 2014 Mar;13(3):364-6.
A multicenter study of the safety and effectiveness of hyaluronic acid with a cohesive polydensified matrix for treatment of nasolabial folds in subjects with Fitzpatrick skin types IV, V, and VI.
Downie JB, Grimes PE, Callender VD.
Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):41S-47S. doi: 10.1097/PRS.0b013e318299ff53.
Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P, Watson J.
Cutis. 2013 Jan;91(1):47-54.
The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.
Grimes PE, Hamzavi I, Lebwohl M, Ortonne JP, Lim HW.
JAMA Dermatol. 2013 Jan;149(1):68-73. doi: 10.1001/2013.jamadermatol.386.
Surgical reconstruction of nasal sarcoidosis: a case report.
Lesavoy MA, Shirvanian VN, Grimes P.
Ann Plast Surg. 2010 Jun;64(6):800-2. doi: 10.1097/SAP.0b013e3181b4051b. Review.
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N.
J Drugs Dermatol. 2010 May;9(5):549-58.
Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.
Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, Nordlund JJ, Rendon M, Taylor S, Gottschalk RW, Agim NG, Ortonne JP.
J Am Acad Dermatol. 2011 Jan;64(1):78-83, 83.e1-2. doi: 10.1016/j.jaad.2009.10.051. Epub 2010 Apr 15.
Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
Grimes PE, Bhawan J, Guevara IL, Colón LE, Johnson LA, Gottschalk RW, Pandya AG.
J Am Acad Dermatol. 2010 Jun;62(6):962-7. doi: 10.1016/j.jaad.2009.06.067. Epub 2010 Apr 15.
A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.
Fu JJ, Hillebrand GG, Raleigh P, Li J, Marmor MJ, Bertucci V, Grimes PE, Mandy SH, Perez MI, Weinkle SH, Kaczvinsky JR.
Br J Dermatol. 2010 Mar;162(3):647-54. doi: 10.1111/j.1365-2133.2009.09436.x.
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
Bhawan J, Grimes P, Pandya AG, Keady M, Byers HR, Guevara IL, Colón LE, Johnson LA, Gottschalk R.
Am J Dermatopathol. 2009 Dec;31(8):794-8. doi: 10.1097/DAD.0b013e3181a9070d.
Safety and effectiveness of hyaluronic acid fillers in skin of color.
Grimes PE, Thomas JA, Murphy DK.
J Cosmet Dermatol. 2009 Sep;8(3):162-8. doi: 10.1111/j.1473-2165.2009.00457.x.
Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
Marmur ES, Taylor SC, Grimes PE, Boyd CM, Porter JP, Yoo JY.
Dermatol Surg. 2009 Oct;35 Suppl 2:1641-5. doi: 10.1111/j.1524-4725.2009.01311.x. Epub 2009 Aug 25.
Postinflammatory hyperpigmentation.
Taylor S, Grimes P, Lim J, Im S, Lui H.
J Cutan Med Surg. 2009 Jul-Aug;13(4):183-91. Review.
Practical applications of genomics research for treatment of aging skin.
Kaczvinsky JR Jr, Grimes PE.
J Drugs Dermatol. 2009 Jul;8(7 Suppl):s15-8.
Management of hyperpigmentation in darker racial ethnic groups.
Semin Cutan Med Surg. 2009 Jun;28(2):77-85. doi: 10.1016/j.sder.2009.04.001. Review.
A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma.
Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, Hexsel D, Im S, Lim J, Lui H, Pandya A, Picardo M, Rendon M, Taylor S, Van Der Veen JP, Westerhof W.
J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1254-62. doi: 10.1111/j.1468-3083.2009.03295.x. Epub 2009 May 19.
A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI.
Grimes PE, Shabazz D.
Dermatol Surg. 2009 Mar;35(3):429-35; discussion 435-6. doi: 10.1111/j.1524-4725.2009.01063.x. Epub 2009 Feb 22.
Phase 4 study to assess tretinoin pump for the treatment of facial acne.
Eichenfield LF, Nighland M, Rossi AB, Cook-Bolden F, Grimes P, Fried R, Levy S; PUMP Study Group.
J Drugs Dermatol. 2008 Dec;7(12):1129-36.
An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Cutis. 2007 Dec;80(6):497-502.
Effects of human subjects requirements on classroom research: multidisciplinary evidence.
Lopus JS, Grimes PW, Becker WE, Pearson RA.
J Empir Res Hum Res Ethics. 2007 Sep;2(3):69-78. doi: 10.1525/jer.2007.2.3.69.
The safety of hydroquinone.
Nordlund J, Grimes P, Ortonne JP.
J Cosmet Dermatol. 2006 Jun;5(2):168-9. No abstract available.
Nordlund JJ, Grimes PE, Ortonne JP.
J Eur Acad Dermatol Venereol. 2006 Aug;20(7):781-7. Review.
Confusions about color: formulating a more precise lexicon for pigmentation, pigmentary disorders, and abnormalities of "chromatics".
Nordlund JJ, Ortonne JP, Cestari T, Grimes P, Chan H.
J Am Acad Dermatol. 2006 May;54(5 Suppl 2):S291-7. No abstract available.
Increasing our understanding of pigmentary disorders.
Grimes P, Nordlund JJ, Pandya AG, Taylor S, Rendon M, Ortonne JP.
J Am Acad Dermatol. 2006 May;54(5 Suppl 2):S255-61. Review.
Community-based trial of a triple-combination agent for the treatment of facial melasma.
Grimes P, Kelly AP, Torok H, Willis I.
Cutis. 2006 Mar;77(3):177-84.
Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
Grimes P, Callender V.
Cutis. 2006 Jan;77(1):45-50.
Microdermabrasion.
Dermatol Surg. 2005 Sep;31(9 Pt 2):1160-5; discussion 1165. Review.
Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.
Grimes PE, Yamada N, Bhawan J.
Am J Dermatopathol. 2005 Apr;27(2):96-101.
Filters: Manage Filters